Short-course penicillin therapy for meningococcal disease: Accumulating evidence and persistent uncertainty

Clinical Infectious Diseases

Volumn 37, Issue 5, 2003, Pages 663-664

  Quagliarello, Vincent ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; PENICILLIN G;

ANTIBIOTIC THERAPY; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CLINICAL TRIAL; COHORT ANALYSIS; DEATH; DRUG EFFICACY; EDITORIAL; FOLLOW UP; GENE AMPLIFICATION; HEALTH CARE; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MENINGOCOCCOSIS; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT OUTCOME;

ADULT; DEVELOPING COUNTRIES; DRUG ADMINISTRATION SCHEDULE; HUMANS; MENINGOCOCCAL INFECTIONS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEISSERIA MENINGITIDIS; PENICILLINS;

EID: 0041830383     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377209     Document Type: Editorial

References (3)

1. Apicella MA. Neisseria meningitidis. In: Mandell G, Bennett J, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. New York: Churchill Livingstone, 2000:2228-41.
2. Raffel C, Ellis-Pegler RB. Short course treatment for meningococcal disease. Infect Dis Clin Pract 1998; 7:369-71.
3. Ellis-Pegler R, Galler L, Roberts S, Thomas M, Woodhouse A. Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults. Clin Infect Dis 2003; 37:658-62 (in this issue).